Matthews Kirstin W, Mueller-Ortiz Stacey L, Wetsel Rick A
Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas-Houston, 2121 West Holcombe Blvd, Houston, TX 77030, USA.
Mol Immunol. 2004 Jan;40(11):785-93. doi: 10.1016/j.molimm.2003.10.002.
Carboxypeptidase N (CPN) is a plasma zinc metalloprotease, which consists of two enzymatically active small subunits (CPN1) and two large subunits (CPN2) that protect the protein from degradation. CPN cleaves carboxy-terminal arginines and lysines from peptides found in the bloodstream such as complement anaphylatoxins, kinins, and creatine kinase MM (CK-MM). By removing only one amino acid, CPN has the ability to change peptide activity and receptor binding. CPN is a member of a larger family of carboxypeptidases, many of which also cleave arginine and lysine. Because of the highly conserved active sites and the possible redundant functions of carboxypeptidases, it has been difficult to elucidate the role of CPN in disease processes. The future use of gene ablation technology may be the most appropriate way to understand the function of CPN in vivo.
羧肽酶N(CPN)是一种血浆锌金属蛋白酶,它由两个具有酶活性的小亚基(CPN1)和两个保护该蛋白不被降解的大亚基(CPN2)组成。CPN从血液中发现的肽类物质(如补体过敏毒素、激肽和肌酸激酶MM(CK-MM))上切割羧基末端的精氨酸和赖氨酸。通过仅去除一个氨基酸,CPN有能力改变肽的活性和受体结合。CPN是一个更大的羧肽酶家族的成员,其中许多也切割精氨酸和赖氨酸。由于羧肽酶的活性位点高度保守且可能具有冗余功能,因此很难阐明CPN在疾病过程中的作用。未来使用基因敲除技术可能是了解CPN体内功能的最合适方法。